Procedure
eFTR
eFTR is a medical procedure with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 31 (50.0%)
N/A1 (50.0%)
Trials by Status
recruiting133%
unknown267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_3
Endoscopic Therapy Or Surgery for Early Colon Cancer
NCT06940947
unknownnot_applicable
Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors
NCT06121752
unknown
Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD
NCT03096236
Clinical Trials (3)
Showing 3 of 3 trials
NCT06940947Phase 3
Endoscopic Therapy Or Surgery for Early Colon Cancer
NCT06121752Not Applicable
Device Assisted Full Thickness Resection Versus Endoscopic Submucosal Dissection for Duodenal Neuroendocrine Tumors
NCT03096236
Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3